LiveWire Ergogenics Begins Process to Return to
Full SEC Reporting Status and Uplist to OTCQB  
Anaheim, CA – April 5, 2018 - LiveWire Ergogenics, Inc. (OTC: LVVV) announced today that it has retained AMC Auditing of Las Vegas, Nevada to audit the Company’s operations and financials to comply with SEC Reporting requirements for small SEC-reporting companies. The company will also provide the OTC Markets Group with the materials required to be up-listed to OTCQB. Until this process has been completed, the Company will continue to file its unaudited financials as required by OTC Markets.
Retaining an auditor, becoming an SEC-filing company and being listed on OTCQB are all important to the long-term plans of LiveWire Ergogenics, which focuses on special purpose real estate acquisitions and asset management, research partnerships, cannabis product development and certification via the Company’s "7X Pure" Cannabis Compliance and Dosage Verification System, and the licensing and management of turnkey production facilities for cannabis-based products and services.

Bill Hodson, CEO of LiveWire, stated, “We are delighted that we are in a position to return to the status of a fully SEC-reporting company and to up-list to OTCQB. We have spent the last two years rebuilding LiveWire and establishing our company as a significant force in the legal cannabis market in California, making sure that our activities are in strict compliance with all State and local laws and regulations.”

LiveWire has obtained the required permits for cannabis nursery/cultivation and distribution from the city of Coachella in California, allowing the Company to begin production soon. In preparation for the up-listing to OTCQB, the company has filed unaudited financial statements for the past two years. Returning to being a fully SEC-reporting company will result in complete operational and financial transparency.

“We hope that providing fully audited financial statements that allow us to be quoted on the OTCQB again will provide our existing shareholders and the general investment community with the confidence to continue supporting the Company,” adds Mr. Hodson. “We have already seen a significant increase in share price over the last several months and believe that this decision for complete transparency could also support new investors in their decision to acquire positions in LiveWire.”
For more information about LiveWire Ergogenics visit or follow the Company on . You can download the SWI Research Report at
About LiveWire Ergogenics, Inc.
LiveWire Ergogenics, Inc. (LVVV) specializes in identifying and monetizing current and future trends in the health and wellness industry. The Company is currently focused on establishing, licensing and leasing legally fully compliant cannabis production facilities and entering into research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for human and veterinarian applications. This includes the cloning of cannabis strains to produce positive medicinal results, dosing verification of zero pesticide products for quality brands via the Company’s “7X Pure” Cannabis Compliance and Dosage Verification System, and development and licensing of high-quality cannabinoid-based products and services. The team at LiveWire Ergogenics has a passion for research and is committed to generating and implementing innovative ideas and producing high-quality products that satisfy an increasing demand in this fast-growing industry.

Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, financial projections, statements regarding the plans and objectives of management for future operations, the development, regulatory approvals and commercialization of the Company’s products, or any of the Company’s other proposed products, systems or services. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and actual events may differ considerably. Factors that may cause actual results to differ materially from any projections may include, without limitation, the Company’s inability to obtain additional financing, delays in the development of its products, the impact of significant government regulation in the cannabis industry, existing or increased competition, results of arbitration and litigation, stock volatility and illiquidity, and the Company’s failure to implement the Company’s business plans or strategies. The Company assumes no obligation to update any forward-looking statements to reflect any event or circumstance that may arise after the date of this release.

EquiNet, LLC
Toll free: 877-964-6463
Direct: 858-264-6500

1600 North Kraemer Blvd.
Anaheim, CA 92806
If you want to follow all other companies that we cover with more in depth research reports, go to our research site at to download the reports,
or visit for up to date news on the covered companies.
Please feel free to re-distribute the reports to your friends and colleagues.
Coverage of LiveWire Ergogenics initiated on August 16, 2017
StockWatchIndex and SWI Research (SWI) are not registered investment advisers and the information provided herein or any other SWI publication is not to be construed as personal financial advice, or a solicitation to buy or sell stock. SWI makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in its publications or on its web sites. Some of the published information has been provided by the companies covered, generated by publicly available sources, or what SWI deems to be reliable third party entities, but SWI does not guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or warrant any results from use of the information. Readers are encouraged to consult their personal financial adviser before making any decisions to buy, sell or hold any securities mentioned herein. StockWatchIndex is not responsible for any error, mistake or shortcoming that may be occasioned at the time of publishing of the information in this publication, any other SWI publication, or its web sites and is not obligated to update and/or correct information. No liability is accepted by StockWatchIndex whatsoever for any direct, indirect or consequential loss arising from the use of the information. SWI expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information provided. SWI has been compensated with five million restricted shares (subject to the restrictions of rule 144) by the Company  for the dissemination of this and future releases and  for continuing consulting and advisory services. The included information is subject to change without notice. Please visit!legal-ease/lmvw1   for a full text of our Disclaimer, Privacy policy and Terms of Use.